Key points are not available for this paper at this time.
Atrial fibrillation (AF) is a supraventriculartachyarrhythmia characterized by uncoordinated atrial activation with associated deterioration of atrial mechanical function.1 It is the most common cardiac arrhythmia, be-comes more prevalent with age,2 and is associated with an increased long-term risk of stroke, heart failure, and all-cause mortality.3 AF can occur in the absence of underlying heart disease but is more frequent in connection with mitral valve disease, heart failure, ischemic heart disease, and hyperten-sion.4 The most frequent pathological observations in AF are atrial fibrosis and loss of atrial muscle mass.5,6 Although the severity of fibrosis reflects the duration of preexisting AF,7 fibrosis can also occur in association with inflammation in the absence of other cardiac pathology6 and may contribute to the onset of AF.8 Molecular, ionic, and genetic influences have all been implicated in AF and are reviewed in detail else-
O’Neill et al. (Mon,) studied this question.